Crowley John J

CIK 00015879723 companiesCHESHIRE

SEC Profile

Transactions

Companies

Filings

CIK

0001587972

Recent Transactions

50 trades

Disposition to Issuer
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2026-06-24−181,000→ 0 total
Disposition to Issuer
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2026-06-24−45,000→ 0 total
Disposition to Issuer
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2026-06-24−600,000→ 0 total
Disposition to Issuer
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2026-06-24−250,000→ 0 total
Award
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2026-02-02+45,000→ 45,000 total
Award
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2026-02-02+181,000→ 181,000 total
Award
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2025-02-03+250,000→ 250,000 total
Award
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2024-07-01+600,000→ 600,000 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−167,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−313,359→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−106,100→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−60,852→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−250,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Restricted Stock Units
2024-06-04−63,700→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−26,972→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−138,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Common Stock
2024-06-04−10,410→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−38,561→ 0 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-01-04+106,100→ 106,100 total
Award
Fusion Pharmaceuticals Inc.
Restricted Stock Units
2024-01-04+63,700→ 63,700 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2023-01-05+250,000→ 250,000 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2022-02-01+167,000→ 167,000 total
Award
Fusion Pharmaceuticals Inc.
Common Stock
2021-08-31+3,910→ 10,410 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2021-02-04+138,000→ 138,000 total
Purchase
Fusion Pharmaceuticals Inc.
Common Stock
2020-06-30$17.00/sh+6,500→ 6,500 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2020-06-25+26,972→ 26,972 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2020-06-25+60,852→ 60,852 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2020-02-06+38,561→ 38,561 total
Tax Payment
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2016-10-01$83.34/sh−284→ 5,599 total
Exercise/Conversion
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Stock Options (Right to Buy)
2016-05-24−1,000→ 2,000 total
Sale
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2016-05-24$85.00/sh−1,913→ 5,883 total
Exercise/Conversion
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2016-05-24$59.41/sh+913→ 7,796 total
Exercise/Conversion
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2016-05-24$46.62/sh+1,000→ 6,883 total
Exercise/Conversion
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Stock Options (Right to Buy)
2016-05-24−913→ 1,825 total
Tax Payment
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2016-02-28$73.70/sh−76→ 5,883 total
Tax Payment
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2016-02-27$73.70/sh−68→ 5,959 total
Award
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2016-02-26+1,093→ 6,027 total
Award
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Stock Options (Right to Buy)
2016-02-26+5,360→ 5,360 total
Tax Payment
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2015-10-01$63.52/sh−285→ 4,934 total
Sale
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2015-03-04$76.53/sh−100→ 5,219 total
Exercise/Conversion
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Stock Options (Right to Buy)
2015-03-04−912→ 2,738 total
Sale
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2015-03-04$76.52/sh−300→ 5,731 total
Sale
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2015-03-04$76.53/sh−412→ 5,319 total
Exercise/Conversion
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2015-03-04$59.41/sh+912→ 6,131 total
Sale
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2015-03-04$76.52/sh−100→ 6,031 total
Tax Payment
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2015-02-28$76.67/sh−227→ 5,219 total
Award
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2015-02-27+839→ 5,446 total
Award
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Stock Options (Right to Buy)
2015-02-27+3,699→ 3,699 total
Exercise/Conversion
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2014-11-04$46.62/sh+1,000→ 5,607 total
Exercise/Conversion
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Stock Options (Right to Buy)
2014-11-04−1,000→ 3,000 total

Companies

Recent Filings

Address

C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM

CHESHIRE, WA14 2DT

View on SEC.gov